The Clorox Company $CLX Stock Position Lessened by Pacer Advisors Inc.

Pacer Advisors Inc. reduced its stake in shares of The Clorox Company (NYSE:CLX) by 44.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,189 shares of the company’s stock after selling 8,293 shares during the quarter. Pacer Advisors Inc.’s holdings in Clorox were worth $1,056,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Haverford Trust Co increased its stake in Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after buying an additional 84 shares during the period. Field & Main Bank lifted its stake in shares of Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after acquiring an additional 100 shares during the period. Golden State Wealth Management LLC lifted its stake in shares of Clorox by 28.2% in the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after acquiring an additional 100 shares during the period. Kestra Private Wealth Services LLC boosted its holdings in shares of Clorox by 1.8% in the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares in the last quarter. Finally, Johnson Financial Group Inc. increased its stake in shares of Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after acquiring an additional 109 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE CLX opened at $105.24 on Monday. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The stock has a market capitalization of $12.73 billion, a price-to-earnings ratio of 21.83, a PEG ratio of 3.13 and a beta of 0.54. The stock’s fifty day simple moving average is $96.41 and its 200 day simple moving average is $103.42. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $128.90.

Clorox (NYSE:CLX) last announced its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same period in the prior year, the business posted $2.87 earnings per share. Clorox’s revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 5.82 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. This is a boost from Clorox’s previous quarterly dividend of $1.24. This represents a $5.00 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, August 12th. Clorox’s payout ratio is currently 102.90%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. BNP Paribas Exane cut their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research report on Monday, July 20th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Morgan Stanley dropped their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. JPMorgan Chase & Co. upped their price objective on Clorox from $92.00 to $95.00 and gave the company an “underweight” rating in a report on Tuesday, August 4th. Finally, Jefferies Financial Group cut Clorox from a “buy” rating to a “hold” rating and decreased their target price for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. Twelve analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.